Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05068752
Title Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors HonorHealth Research Institute
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.